NCRI PETREA TRIAL: A PHASE 3 EVALUATION OF PET‐GUIDED, RESPONSE‐ADAPTED THERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED, ADVANCED‐STAGE, HIGH‐TUMOUR‐BURDEN FOLLICULAR LYMPHOMA. (12th June 2019)

• Record Type: Journal Article
• Authors: Pettitt, A.R.; Barrington, S.; Kalakonda, N.; Khan, U.T.; Jackson, R.; Carruthers, S.; Oates, M.; Lin, K.; Ardeshna, K.; Eyre, T.; Fox, C.P.; Kennedy, B.; Linton, K.; Malladi, R.; Menne, T.; Okosun, J.; Paneesha, S.; Rule, S.; Johnston, A.; Trotman, J.
• Is Part Of: Hematological oncology. Volume 37(2019)Supplement 2
• Page Start: 67
• Page End: 68
• Publication Date: 2019-06-12
• Subjects: Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.35_2629
• Languages: English
• ISSNs: 0278-0232